Generalized pustular psoriasis (GPP) is a severe and rare form of psoriasis, being a
potentially life-threatening condition, characterized by recurring episodes or flares of …

ABSTRACT Introduction In 2022, US Food and Drug Administration (FDA) approved the first
biologics, intravenous spesolimab, for acute flare of generalized pustular psoriasis (GPP) …

Loss-of-function sequence variations in the IL36RN gene encoding IL-36 receptor
antagonist cause familial generalized pustular psoriasis, which begins shortly after birth and …

Psoriasis is a common, chronic, immune-mediated, multisystem, inflammatory disorder. It
affects all age groups, including infancy. In one-third of the cases, the onset of the disease is …

Introduction Pustular psoriasis (PP) is a rare subtype of psoriasis. Overall, the growing
evidence–in particular for acute generalized PP (GPP)–supports that it is a separate entity …

Generalized pustular psoriasis (GPP) is a severe subtype of psoriasis, commonly combined
with systemic inflammation. Gene mutations have been found to be associated with GPP …

We report a case of a 3‐year‐old girl with generalized pustular psoriasis (GPP) and a
compound heterozygous mutation within the IL36 receptor antagonist (IL36RN) gene at c …

Background: Generalized pustular psoriasis (GPP) is a diagnostic challenge for clinicians
and is relatively rare. Prevalence is currently reported to be higher in Asian countries and …

Severe dermatitis, multiple allergies, and metabolic wasting (SAM) syndrome is a rare
congenital skin disease. We report on a 16-month-old infant presenting with severe …

Infantile generalized pustular psoriasis with excellent response to secukinumab: A case report
Infantile generalized pustular psoriasis with excellent response to secukinumab: A case report …